BD & Partnering StrategyAcademic TTOs & Research Centers

A decision-ready blueprint

Business Development & Partnering Solutions for Academic Medical Centers

A business development and partnering solution designed around the commercial realities of academic technology transfer offices and research centers.

Discuss this solution Read the overview
Academic technology-transfer professionals review a commercialisation pathway in a biomedical research centre.
PhD and MBA-led Life Science Consultancy
Principal-led accountability

Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.

Under 10 daysGrant-funding application assessmentPublished frameworkCRISPR preclinical-to-clinical decision tree100 → ~20 hoursProposed technical-dossier agent architectureSystem viewExplore the governed operating model

Academic medical and translational centres need a disciplined path from research evidence and intellectual property to the partners, licensees, and commercialisation opportunities that can advance a programme. That work involves distinct institutional responsibilities, research context, partner questions, and approval points that should remain visible throughout the engagement.

Lonrú Consulting designs the partnering architecture around those decisions. We connect the approved research, IP, translational, market, and partner information needed to assess opportunities, prepare a credible external narrative, and manage the next accountable action.

A governed operating model for the decision in view.

  1. Lonrú Context Engineering™

    We define the approved research, IP, translational, clinical, market, partner, and institutional sources relevant to the selected commercialisation or engagement question.

  2. Lonrú Agentic Systems™

    Configured systems can structure evidence, prepare opportunity material, compare defined partner criteria, or support repeatable analysis within the agreed information and review boundaries.

  3. Lonrú Consulting™

    Lonrú provides principal-led strategy, commercial framing, and review governance. Research leads, technology-transfer professionals, institutional decision-makers, and client-selected specialists review work within their accountable areas.

  4. VantagePoint™

    Approved work can be delivered through an opportunity workspace, partner-readiness view, controlled data room, portfolio interface, or decision briefing environment.

What these partnering solutions can deliver.

  • Create a clearer opportunity and partner view

    Relate the approved research, IP, translational evidence, market context, and partner questions that shape an opportunity assessment.

  • Support deliberate out-licensing preparation

    Organise the evidence, assumptions, review needs, and next actions required to prepare an opportunity for a prospective licensee or strategic collaborator.

  • Improve controlled partner engagement

    Design a practical route for preparing, reviewing, and sharing selected opportunity material while respecting institutional approval and information boundaries.

  • Focus commercialisation effort on the right questions

    Bring the relevant landscape, partner, and opportunity signals into a decision view that helps technology-transfer and research leaders prioritise the next action.

Keep institutional governance in the partnering model.

The architecture works with the institution's own research, IP, publication, and commercialisation responsibilities. It does not publish confidential research, make unapproved claims, or replace the decisions held by researchers and technology-transfer teams.

We define the information that can be prepared for partner engagement, the approval points required before external sharing, and the people who remain accountable for the final decision.

Relevant experience

Evidence that informs this work.

Under 10 days

Grant-funding application assessment

Working through a partner consultancy, Lonrú assessed detailed technical grant applications for a prominent U.S. Academic Medical Center in cell and gene therapy in under 10 days; the programme’s previous external assessment had taken four weeks. Lonrú expanded the ranking criteria with business-development and commercial-opportunity analysis, created a weighted scoring matrix, and provided evidence-backed scoring rationales. The principal investigator whose application ranked highest through Lonrú’s analysis received the grant award.

Published framework

CRISPR preclinical-to-clinical decision tree

Published a CRISPR preclinical-to-clinical decision-tree framework with Johns Hopkins Carey Business School affiliation, combining IND/CTA pathway comparisons across FDA, EMA, MHRA, PMDA, and NMPA with decision points for editing specificity, long-term safety, and in-vivo versus ex-vivo risk.

100 → ~20 hours

Proposed technical-dossier agent architecture

Prepared a proposal for a life-sciences technical organisation whose SMEs spent up to 100 hours producing a technical dossier. The proposed architecture coordinated technical, quality-control, and reference agents to assemble traceable citations and format the output for the FDA submission system, with an estimated reduction to approximately 20 hours of SME source validation and verification before external legal review.

Architecture in context

ActiveArchitecture™ in context

Diagram summary: Research, IP, translational, market, and partner evidence is contextualised, analysed, and tested through ActiveArchitecture™ before it supports a commercialisation or licensing decision.

Practical questions

Questions clients raise before a briefing.

Yes. The architecture can distinguish internal evidence and decision work from material prepared for external sharing, with access, approval, and review points defined for the selected workflow.

Next step

Discuss the first useful workstream.

Bring the decision, workflow, or delivery constraint that needs a clearer operating path.

Request a focused briefing
Related Strategic Focus

Cross-Functional Industry Solutions

Explore Full Directory →

Solutions for Academic TTOs & Research Centers

BD & Partnering Strategy for Other Segments